S 832 · 119th Congress 2025–2027

EPIC Act of 2025

Latest action · Mar 4, 2025 Read twice and referred to the Committee on Finance.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedMar 4, 2025
  2. Passed SenateNot reached
  3. Passed HouseNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Ensuring Pathways to Innovative Cures Act of 2025 or the EPIC Act of 2025

This bill lengthens the amount of time for which drug products must have market approval in order for the products to qualify for negotiation under the Medicare Drug Price Negotiation Program.

The Medicare Drug Price Negotiation Program requires the Centers for Medicare & Medicaid Services to negotiate the prices of certain prescription drugs under Medicare beginning in 2026. Among other requirements, drugs must have had market approval for at least 7 years (for drug products) or 11 years (for biologics) to qualify for negotiation. 

The bill modifies these provisions so as to require drug products to also have had at least 11 years of market approval in order to qualify for negotiation beginning in 2028.

Cosponsors 7

Members who signed on, in the order they did. Signatures ran from Mar 4, 2025 to Apr 29, 2025; 4 are original cosponsors, there from the day it was introduced.

SeatCosponsorSigned on
R-OKJames LankfordOriginalMar 4, 2025
R-TNMarsha BlackburnOriginalMar 4, 2025
R-MTSteve DainesOriginalMar 4, 2025
R-NCTed BuddOriginalMar 4, 2025
R-UTJohn R. CurtisApr 10, 2025
R-INJim BanksApr 29, 2025
R-KSRoger MarshallApr 29, 2025

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
SenateFinance Committee
Referred Mar 4, 2025

Actions 2

Everything that happened, newest first.

  1. Mar 4, 2025Introduced in Senate
  2. Mar 4, 2025Read twice and referred to the Committee on Finance.

Titles 3

Every title it has carried, official and short, at each stage.

Official Title as Introduced
A bill to amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Short Title(s) as Introduced
EPIC Act of 2025
Ensuring Pathways to Innovative Cures Act of 2025

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Mar 4, 2025Introduced in Senate

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.